Clinical trials: Preserved Left Ventricular Systolic Function
- Condition Preserved Left Ventricular Systolic Function
- Funder type Industry (pharma, biotech, devices)
Congestive Heart Failure
Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
A study to evaluate the effect of Atacand on patients with heart failure with preserved left ventricular function
- Trial name
- NCT00634712
- Testing
- Candesartan
- Volunteers
- 734 people
- Sponsor
- AstraZeneca